HALISTER: Endo Buys Par Pharma for $8.05 Billion Amid Deal Hunt (Correct)

Endo Buys Par Pharma for $8.05 Billion Amid Deal Hunt (Correct)

Alert: HALISTER Source: BN (Bloomberg News)

Tickers ENDP US (Endo International PLC) 8818Z US (TPG Capital Management LP) VRX CN (Valeant Pharmaceuticals International Inc)

People David Bonderman (Tpg Advisors V Inc) Michael Faerm (Wells Fargo & Co) Paul Campanelli (Par Pharmaceutical Cos Inc) Rajiv De Silva (Endo International PLC)

To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.

UUID: 7947283